2DG acts as a simple sugar analog by interfering with the breakdown of glucose, especially in malignant cancer cells. As the tumor grows, its glucose consumption ratio increases. Using 2DG therapy helps to block the cancer cells’ requirement for more glucose, thus depriving cancer cells of energy they need for survival.
